Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.0400 (-0.28%) ($13.9300 - $14.2500) on Mon. Oct. 7, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.9% (three month average) | RSI | 36 | Latest Price | $14.0400(-0.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -5.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.95% in a week (0% probabilities). VIXM(-36%) VXX(-35%) TLT(-12%) UNG(-7%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.95% (StdDev 3.9%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
Resistance Level | $14.64 | 5 Day Moving Average | $13.79(1.81%) | 10 Day Moving Average | $13.91(0.93%) | 20 Day Moving Average | $14.64(-4.1%) | To recent high | -24.9% | To recent low | 16.7% | Market Cap | $1.043b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |